Annual revenue of Shanghai Pharmaceuticals 2011-2022

Published by
Wenyi Zhang,
Aug 7, 2023
This statistic shows the revenue of Shanghai Pharmaceutical Group Co., Ltd. from 2011 to 2022. In 2022, SPGC generated a revenue of approximately 232 billion yuan, indicating a steady growth over the past decade.

Annual revenue of Shanghai Pharmaceutical Group (SPGC) from 2011 to 2022 (in billion yuan)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2023

Region

China

Survey time period

2011 to 2022

Supplementary notes

One yuan equals approximately 0.14 U.S. dollars and 0.13 euros (as of August 2023).

Figures have been rounded.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in China "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in China

Key Figures

7

Drug evaluation and approval

8

Sales channels

7

Pharmaceutical enterprises

7

Further related statistics

14

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in ChinaCoronavirus COVID-19 in ChinaPharmaceutical industry in JapanVaccine industry in ChinaPharmaceuticals in India
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.